GSK 315234
Alternative Names: 315234; GSK315234; GSK315234ALatest Information Update: 05 Nov 2023
Price :
$50 *
At a glance
- Originator GlaxoSmithKline
- Class Antirheumatics; Monoclonal antibodies
- Mechanism of Action Oncostatin M modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 21 Oct 2009 Adverse events, pharmacokinetics and pharmacodynamics data from a phase I trial in Rheumatoid arthritis presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology and the 44th Annual Meeting of the Association of Rheumatology Health Professionals (ACR/ARHP-2009)